Abstract
Ups1 is a soluble MSF1/PRELI-family mitochondrial phosphatidic acid (PA) transporter required for cardiolipin synthesis in the inner mitochondrial membrane (IMM). Mdm35, a mitochondrial intermembrane space (IMS)-resident protein, is required for the import and maintenance of functional Ups1 in the IMS, but the mechanisms of this dependency and of lipid transfer by the complex were unknown. Yu et al. {1} and Watanabe et al. independently reported structures of the Ups1/Mdm35 complex. Strikingly, unlike other START-related proteins, which comprise a single polypeptide, Ups1 and Mdm35 cooperate to form a functional START domain. This feature is key to the regulation of PA transport activity in the IMS and sheds new light on the diverse regulatory mechanisms governing the growing family of non-vesicular lipid transfer proteins. In each crystal structure, Ups1 lacks an N-terminal helix that in other START domain proteins packs against the protein surface. Mdm35, a small protein of only 86 residues, binds a similar face of Ups1 and may function partly as a substitute for this bracing helix. Both groups found that this interaction stabilizes Ups1 and likely ensures that Ups1 is functional only in the mitochondrial IMS, restricting its PA transfer activity to this compartment. Both groups identified several key features that provide insights into PA binding and transfer by Ups1/Mdm35. PA binds head-first within a Ups1 cavity lined with hydrophobic residues, but with a key hydrophilic residue (Arg25) deep within the cavity that positions the head group. Like other START-domain proteins, Ups1 contains a lid structure at the opening of the cavity required for complex activity both in vitro and in vivo. Intriguingly, the lid exhibits high temperature factors and adopts different conformations in the Yu and Watanabe structures, suggesting a possible conformational change required for lipid extraction. Finally, a hydrophilic patch on the surface of Ups1 near the opening of the PA binding cavity is required for CL-specific membrane binding of the complex, as well as PA binding and transfer. In vivo, Ups1 binding to CL in the IMM is thought both to recruit it to deliver PA and, under high CL conditions, to sequester it on the IMM to prevent further PA transfer, serving to regulate its activity. In a further insight, Watanabe et al. discovered that transient Mdm35 dissociation is required for Ups1 activity. Using different strategies to tether the proteins together, they found that PA transfer occurs only when binding between Ups1 and Mdm35 is reversible. Though not reviewed here, another important paper, published alongside Yu et al., describes the structure of the TRIAP1-SLMO1 complex, another member of the PRELI protein family {2}. Together, these represent the first known structures of PRELI family proteins and make an important new contribution to our understanding of the large (and expanding) family of lipid transfer proteins.